a public good project by the
Synthesis
Company
of California

© 2026

Jochen H. Lorch | doi.page

0 works0 citations0 h-index

Jochen H. Lorch

Northwestern University(US)Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Publications by Year

Research Areas

Head and Neck Cancer Studies, Thyroid Cancer Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Salivary Gland Tumors Diagnosis and Treatment, Cancer Genomics and Diagnostics

Most-Cited Works

→ Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial(2016)1,206 cited
→ CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation(2017)756 cited
→ Efficacy of Selpercatinib in RET -Altered Thyroid Cancers(2020)741 cited
→ Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial(2013)739 cited
→ Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids(2017)559 cited
→ Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial(2011)486 cited

→ Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial(2011)

439 cited

→ Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma(2020)333 cited

→ Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial(2018)328 cited

→ Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer(2014)325 cited